Intraocular Melanoma Completed Phase 2 Trials for Pyrazoloacridine (DB12549)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003802Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaTreatment